Home LiteratureArticle Details
PMID: 4248913 Published · ppublish English Journal Article

Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets.

The Journal of clinical investigation ·Vol. 49 ·No. 11 ·1970-11-00 ·Pages 2068-85

Taylor FB, Müller-Eberhard HJ

Abstract

Dilute whole blood clots were prepared by addition of thrombin to blood diluted 1:10 in phosphate buffer. The pH of this buffer was 7.4 and the ionic strength was 0.084. Though the ionic strength was low, there was no hemolysis of red corpuscles due to the contribution to the osmotic gradient by plasma salts and proteins. In the standard assay the clot was formed by addition of thrombin at 4 degrees C then incubated at 37 degrees C. Retraction and lysis of these clots were inhibited by removal of platelets and by increasing concentrations of purified thrombin. Retraction and lysis were also inhibited by inactivation of any one of the following factors: gammaM globulin, complement components C4 and 3, and (in the case of lysis) plasminogen. Evidence that some of the above serum factors were adsorbed to the platelet membrane was obtained by aggregation of washed platelets by antisera to these factors (i.e. fibrinogen, gammaM, and C4 or C3). These platelets were not aggregated by antisera to other serum proteins (by albumin, transferrin, gammaG globulin). These and other studies suggested that platelets, thrombin, fibrinogen, gammaM globulin (cold agglutinin), complement components, and plasminogen influenced and facilitated retraction and lysis of clots. These studies also suggested that platelets and some of these factors were physically associated. Because of this physical association, and because of the fact that clot retraction is associated with aggregation and retraction of platelets, we extended the above observations to include a study of the effect of these same serum factors on serum-induced aggregation and retraction of washed platelets. (Other terms which have been in use in the past to describe serum-induced platelet aggregation and retraction have included those such as platelet "fusion" and "viscous metamorphosis," neither of which fully described the phenomena.)Platelet aggregation and retraction induced by serum was markedly accelerated by addition of increasing concentrations of thrombin and (or) cold agglutinin. Hirudin and antisera to gammaM globulin inhibited seruminduced aggregation and retraction of platelets. Reconstitution of inactivated serum with purified C4, 3, and 5 and thrombin restored its capacity to induce aggregation and retraction of platelets.Therefore, we postulated that platelet aggregation and retraction were necessary for clot retraction and that platelet aggregation and clot retraction facilitated clot lysis. More specifically we postulated that thrombin, in addition to catalyzing clot formation, also modified the platelet membrane such that gammaM globulin (cold agglutinin) and complement components can act on the platelet membrane leading to (a) aggregation and retraction of the platelets, (b) retraction of the clot, and (c) to the activation of plasminogen either on the surface of the platelet by C8i and (or) by release of platelet activators of plasminogen.

MeSH Terms
Antibodies Blood Coagulation Blood Coagulation Tests Blood Platelets Buffers Cell Membrane Clot Retraction Complement System Proteins/pharmacology Fibrinogen/pharmacology Fibrinolysin/pharmacology Hemolysis Hirudins/pharmacology Humans Hydrogen-Ion Concentration Immunoglobulin M Methods Plasminogen/pharmacology Platelet Adhesiveness Thrombin/pharmacology Time Factors Venoms/pharmacology
Chemicals
Antibodies Buffers Hirudins Immunoglobulin M Venoms Fibrinogen Plasminogen Complement System Proteins Thrombin Fibrinolysin
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Taylor F B
Müller-Eberhard H J
References (23)
23 references, click to expand
  1. IMMUNOLOGIC STUDIES OF PLATELET PROTEIN.
    Blood. 1965 May;25:703-11 PMID: 14282039
  2. ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.
    J Exp Med. 1965 Aug 1;122:277-98 PMID: 14316946
  3. ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT.
    J Exp Med. 1963 Sep 1;118:447-66 PMID: 14078003
  4. STUDIES ON HUMAN C'1-ESTERASE. I. PURIFICATION AND ENZYMATIC PROPERTIES.
    J Immunol. 1964 Mar;92:456-67 PMID: 14128991
  5. Factors influencing lysis of whole blood clots.
    Nature. 1967 Dec 9;216(5119):1023-5 PMID: 4169258
  6. DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.
    Ann N Y Acad Sci. 1964 Dec 28;121:404-27 PMID: 14240539
  7. Isolation and characterization of two beta1-glycoproteins of human serum.
    J Exp Med. 1960 Feb 1;111:201-15 PMID: 13726744
  8. The reaction mechanism of beta-1C-globulin (C'3) in immune hemolysis.
    J Exp Med. 1966 Jan 1;123(1):33-54 PMID: 4159289
  9. Studies of the plasmin system. I. Measurement of human and animal plasminogen; measurement of an activator in human serum.
    J Exp Med. 1957 Sep 1;106(3):423-37 PMID: 13463252
  10. Measurements of complement by agglutination of human erythrocytes reacting in immune-adherence.
    J Immunol. 1963 Jan;90:86-97 PMID: 13938807
  11. Purification and characterization of streptokinase with studies of streptokinase activation of plasminogen.
    Biochemistry. 1968 Jan;7(1):232-42 PMID: 4098209
  12. Platelet aggregation, adhesion and adenosine diphosphate release in thrombopathia (platelet factor 3 deficiency). A comparison with Glanzmann's thrombasthenia and von Willebrand's disease.
    Am J Med. 1967 Oct;43(4):570-8 PMID: 5299408
  13. Fibrinolysis.
    N Engl J Med. 1961 Jan 12;264:79-84 contd PMID: 13694440
  14. Fibrinogen from human plasma: preparation by precipitation with heavy-metal coordination complex.
    Science. 1967 Feb 24;155(3765):1017-9 PMID: 6017979
  15. Influence of blood platelets on fibrinolysis.
    Thromb Diath Haemorrh. 1961 Sep 1;6:196-214 PMID: 13908333
  16. ROLE OF PLATELETS IN DISSOLUTION OF BLOOD CLOTS.
    Nature. 1963 Aug 10;199:610-1 PMID: 14072019
  17. Lipaemia and fibrinolytic potentiality.
    Lancet. 1960 Jan 23;1(7117):186-8 PMID: 14403359
  18. Evidence of a diurnal fibrinolytic rhythm; with a simple method of measuring natural fibrinolysis.
    Clin Sci (Lond). 1957 Nov;16(4):645-50 PMID: 13489905
  19. Chromatography, physical characteristics, and disulfide bonds of euglobulin plasminogen.
    Arch Biochem Biophys. 1966 Apr;114(1):38-49 PMID: 4162977
  20. Platelet enzymes.
    Thromb Diath Haemorrh Suppl. 1967;26:143-54 PMID: 4294307
  21. Platelet function in a patient with thrombasthenia.
    Blood. 1966 Oct;28(4):524-34 PMID: 5923606
  22. The presence of cold haemolysins in sera containing cold haemagglutinins.
    J Pathol Bacteriol. 1950 Apr;62(2):241-57 PMID: 15437250
  23. Some effects of divalent cations on the clotting mechanism and the platelets of EDTA blood.
    J Appl Physiol. 1958 May;12(3):453-60 PMID: 13525310
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1970-11-00
Pages
2068-85
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC535783
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com